FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
JD Supra1h
FDA Bans Red Dye No. 3 in Food and Ingested Drugs: What Manufacturers Should Know
On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...
FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
healthday4h
FDA Approves First New Non-Opioid Pain Pill in Decades
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction ...
MarketWatch on MSN10d
Here are the food additives and dyes you eat that could be banned next
With the recent news that the Food and Drug Administration is banning Red No. 3, the artificial dye that is considered a ...
New York man arrested for injecting fake Botox: Prosecutors
A New York aesthetician was arrested on Wednesday for allegedly buying counterfeit Botox from China and injecting it into ...
Trump Administration Temporarily Mutes Federal Health Officials
Scientific meetings were canceled, and research data on the bird flu outbreak was delayed, amid confusion over the directive.
The Washington Post3d
Americans might finally have to face what’s in their food
(Scott Olson/Getty Images) In the final days of the Biden administration, the Food and Drug Administration proposed ... I hope he’s right. The new administration should build upon the decades ...
New type of non-opioid pain medication approved by FDA
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.